ANI Pharmaceuticals, Inc.
USD83.57
-0.54 (-0.65%)
CEO
Nikhil Lalwani
IPO Date
2000-05-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$84.12
Prev. Close
$84.11
Day Low
$82.66
Day High
$84.12
52W Low
$62.61
52W High
$99.50
Market Cap
$1.90B
Volume
0.06M
| -57.7 |
| 31 Dec 2023 | FY | 62.7% | 3.9% | 4.1% | 2.1% | 0.62 | 3.57 | 52.9 |
| 31 Dec 2022 | FY | 56.1% | -15.1% | -14.1% | -6.3% | 0.85 | 3.46 | -13.7 |
| 31 Dec 2021 | FY | 53.5% | -19.7% | -11.9% | -5.5% | 0.80 | 3.68 | -13.6 |
| 31 Dec 2020 | FY | 58.2% | -10.8% | -11.5% | -4.9% | 0.95 | 2.17 | -15.4 |
| 31 Dec 2019 | FY | 69.4% | 3.0% | 2.9% | 1.3% | 0.87 | 3.04 | 119.8 |
| 31 Dec 2018 | FY | 63.8% | 7.7% | 7.9% | 3.6% | 0.93 | 0.92 | 33.9 |
| 31 Dec 2017 | FY | 55.3% | -0.6% | -0.6% | -0.3% | 1.15 | 3.35 | -691.6 |
| 31 Dec 2016 | FY | 62.1% | 3.1% | 2.3% | 1.2% | 0.71 | 3.22 | 176.4 |
| 14.4 |
| 30 Sept 2025 | Q3 | 49.1% | 10.6% | 4.8% | 1.7% | 0.64 | 2.58 | 19.0 |
| 30 Jun 2025 | Q2 | 64.7% | 4.0% | 1.9% | 0.6% | 1.35 | 2.54 | 37.8 |
| 31 Mar 2025 | Q1 | 62.9% | 8.0% | 3.5% | 1.2% | 1.40 | 2.66 | 20.9 |
| 31 Dec 2024 | Q4 | 57.9% | -5.4% | -2.4% | -0.8% | 1.46 | 2.72 | -26.2 |
| 30 Sept 2024 | Q3 | 57.5% | -16.3% | -5.6% | -1.9% | 1.45 | 2.74 | -12.0 |
| 30 Jun 2024 | Q2 | 58.2% | -1.7% | -0.5% | -0.2% | 0.59 | 3.97 | -134.0 |
| 31 Mar 2024 | Q1 | 64.2% | 13.2% | 3.8% | 2.0% | 0.60 | 3.95 | 17.8 |
| 31 Dec 2023 | Q4 | 59.4% | 0.9% | 0.3% | 0.1% | 0.62 | 3.57 | 226.8 |